• Executive Summary o Market Overview • Market Landscape o Market ecosystem o Value chain analysis • Market Sizing o Market definition o Market segment analysis o Market size 2019 o Market outlook: Forecast for 2019 - 2024 • Five Forces Analysis o Five forces summary o Bargaining power of buyers o Bargaining power of suppliers o Threat of new entrants o Threat of substitutes o Threat of rivalry o Market condition • Market Segmentation by Product o Market segments o Comparison by Product o Artificial heart - Market size and forecast 2019-2024 o Artificial kidney - Market size and forecast 2019-2024 o Cochlear implants - Market size and forecast 2019-2024 o Artificial pancreas - Market size and forecast 2019-2024 o Market opportunity by Product • Customer Landscape • Geographic Landscape o Geographic segmentation o Geographic comparison o North America - Market size and forecast 2019-2024 o Europe - Market size and forecast 2019-2024 o APAC - Market size and forecast 2019-2024 o ROW - Market size and forecast 2019-2024 o Key leading countries o Market opportunity by geography o Volume drivers – Demand led growth o Market challenges o Market trends • Vendor Landscape o Vendor landscape o Landscape disruption • Vendor Analysis o Vendors covered o Market positioning of vendors o Abbott Laboratories o Asahi Kasei Corp. o B. Braun Melsungen AG o Baxter International Inc. o Boston Scientific Corp. o Cochlear Ltd. o F. Hoffmann-La Roche Ltd. o Fresenius Medical Care AG & Co. KGaA o Medtronic Plc o Nipro Corp. • Appendix o Scope of the report o Currency conversion rates for US$ o Research methodology o List of abbreviations Exhibit • 1: Key Finding 1 • 2: Key Finding 2 • 3: Key Finding 3 • 4: Key Finding 5 • 5: Key Finding 6 • 6: Key Finding 7 • 7: Key Finding 8 • 8: Parent market • 9: Market characteristics • 10: Offerings of vendors included in the market definition • 11: Market segments • 12: Global - Market size and forecast 2019 - 2024 ($ million) • 13: Global market: Year-over-year growth 2019 - 2024 (%) • 14: Five forces analysis 2019 & 2024 • 15: Bargaining power of buyers • 16: Bargaining power of suppliers • 17: Threat of new entrants • 18: Threat of substitutes • 19: Threat of rivalry • 20: Market condition - Five forces 2019 • 21: Product - Market share 2019-2024 (%) • 22: Comparison by Product • 23: Artificial heart - Market size and forecast 2019-2024 ($ million) • 24: Artificial heart - Year-over-year growth 2019-2024 (%) • 25: Artificial kidney - Market size and forecast 2019-2024 ($ million) • 26: Artificial kidney - Year-over-year growth 2019-2024 (%) • 27: Cochlear implants - Market size and forecast 2019-2024 ($ million) • 28: Cochlear implants - Year-over-year growth 2019-2024 (%) • 29: Artificial pancreas - Market size and forecast 2019-2024 ($ million) • 30: Artificial pancreas - Year-over-year growth 2019-2024 (%) • 31: Market opportunity by Product • 32: Customer landscape • 33: Market share by geography 2019-2024 (%) • 34: Geographic comparison • 35: North America - Market size and forecast 2019-2024 ($ million) • 36: North America - Year-over-year growth 2019-2024 (%) • 37: Europe - Market size and forecast 2019-2024 ($ million) • 38: Europe - Year-over-year growth 2019-2024 (%) • 39: APAC - Market size and forecast 2019-2024 ($ million) • 40: APAC - Year-over-year growth 2019-2024 (%) • 41: ROW - Market size and forecast 2019-2024 ($ million) • 42: ROW - Year-over-year growth 2019-2024 (%) • 43: Key leading countries • 44: Market opportunity by geography ($ million) • 45: Impact of drivers and challenges • 46: Vendor landscape • 47: Landscape disruption • 48: Industry risks • 49: Vendors covered • 50: Market positioning of vendors • 51: Abbott Laboratories - Overview • 52: Abbott Laboratories - Business segments • 53: Abbott Laboratories - Key offerings • 54: Abbott Laboratories - Key customers • 55: Abbott Laboratories - Segment focus • 56: Asahi Kasei Corp. - Overview • 57: Asahi Kasei Corp. - Business segments • 58: Asahi Kasei Corp. - Key offerings • 59: Asahi Kasei Corp. - Key customers • 60: Asahi Kasei Corp. - Segment focus • 61: B. Braun Melsungen AG - Overview • 62: B. Braun Melsungen AG - Business segments • 63: B. Braun Melsungen AG - Key offerings • 64: B. Braun Melsungen AG - Key customers • 65: B. Braun Melsungen AG - Segment focus • 66: Baxter International Inc. - Overview • 67: Baxter International Inc. - Business segments • 68: Baxter International Inc. - Key offerings • 69: Baxter International Inc. - Key customers • 70: Baxter International Inc. - Segment focus • 71: Boston Scientific Corp. - Overview • 72: Boston Scientific Corp. - Business segments • 73: Boston Scientific Corp. - Key offerings • 74: Boston Scientific Corp. - Key customers • 75: Boston Scientific Corp. - Segment focus • 76: Cochlear Ltd. - Overview • 77: Cochlear Ltd. - Business segments • 78: Cochlear Ltd. - Key offerings • 79: Cochlear Ltd. - Key customers • 80: Cochlear Ltd. - Segment focus • 81: F. Hoffmann-La Roche Ltd. - Overview • 82: F. Hoffmann-La Roche Ltd. - Business segments • 83: F. Hoffmann-La Roche Ltd. - Key offerings • 84: F. Hoffmann-La Roche Ltd. - Key customers • 85: F. Hoffmann-La Roche Ltd. - Segment focus • 86: Fresenius Medical Care AG & Co. KGaA - Overview • 87: Fresenius Medical Care AG & Co. KGaA - Product and service • 88: Fresenius Medical Care AG & Co. KGaA - Key offerings • 89: Fresenius Medical Care AG & Co. KGaA - Key customers • 90: Fresenius Medical Care AG & Co. KGaA - Segment focus • 91: Medtronic Plc - Overview • 92: Medtronic Plc - Business segments • 93: Medtronic Plc - Key offerings • 94: Medtronic Plc - Key customers • 95: Medtronic Plc - Segment focus • 96: Nipro Corp. - Overview • 97: Nipro Corp. - Business segments • 98: Nipro Corp. - Key offerings • 99: Nipro Corp. - Key customers • 100: Nipro Corp. - Segment focus • 101: Currency conversion rates for US$ • 102: Research Methodology • 103: Validation techniques employed for market sizing • 104: Information sources • 105: List of abbreviations

Abbott Laboratories, Asahi Kasei Corp., B. Braun Melsungen AG, Baxter International Inc., Boston Scientific Corp., Cochlear Ltd., F. Hoffmann-La Roche Ltd., Fresenius Medical Care AG & Co. KGaA, Medtronic Plc, Nipro Corp.